{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:20:18Z","timestamp":1778570418174,"version":"3.51.4"},"reference-count":155,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bambino Ges\u00f9 Children's Hospital"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.blre.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T02:46:27Z","timestamp":1458096387000},"page":"297-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Specific removal of alloreactive T-cells to prevent GvHD in hemopoietic stem cell transplantation: rationale, strategies and perspectives"],"prefix":"10.1016","volume":"30","author":[{"given":"Giuseppina","family":"Li Pira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Di Cecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Manca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bcmd.2007.06.022","article-title":"Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation","volume":"40","author":"Perruccio","year":"2008","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.bmt.1705787","article-title":"The probability of identifying a 10\/10 HLA allele-matched unrelated donor is highly predictable","volume":"40","author":"Tiercy","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"10.1016\/j.blre.2016.03.001_bb0015","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2016.03.001_bb0020","series-title":"Hematopoietic cell transplantation","first-page":"904","article-title":"Hematopoietic cell transplantation from HLA partially matched related donors","author":"Anasetti","year":"1999"},{"issue":"8242","key":"10.1016\/j.blre.2016.03.001_bb0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0140-6736(81)90647-4","article-title":"Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells","volume":"2","author":"Reisner","year":"1981","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.blre.2016.03.001_bb0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00007890-198804000-00018","article-title":"T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation","volume":"45","author":"Hale","year":"1988","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.blre.2016.03.001_bb0035","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","article-title":"T-cell depletion of HLA-identical transplants in leukemia","volume":"78","author":"Marmont","year":"1991","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.1986.tb05544.x","article-title":"Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation","volume":"63","author":"Patterson","year":"1986","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0045","first-page":"445","article-title":"Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants","volume":"3","author":"Martin","year":"1988","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.blre.2016.03.001_bb0050","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.83.11.4012","article-title":"Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation","volume":"83","author":"Reisner","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0055","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/00007890-198743060-00014","article-title":"Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. identification of host-derived antidonor allocytotoxic T lymphocytes","volume":"43","author":"Kernan","year":"1987","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.blre.2016.03.001_bb0060","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \u201cthree-loci\u201d incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.03.001_bb0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.blre.2014.09.009","article-title":"\u201cNo donor\u201d? consider a haploidentical transplant","volume":"29","author":"Ciurea","year":"2015","journal-title":"Blood Rev"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0070","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjh.13868","article-title":"The evolution of T-cell depletion in haploidentical transplantation","volume":"172","author":"Or-Geva","year":"2016","journal-title":"Brit J Hematol"},{"key":"10.1016\/j.blre.2016.03.001_bb0075","series-title":"Minimal residual disease in acute leukemia","first-page":"337","article-title":"Soybean lectin agglutination and E-rosette depletion for removal of T-cells from HLA identical marrow grafts","author":"O'Reilly","year":"1986"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1182\/blood.V61.2.341.341","article-title":"Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells","volume":"61","author":"Reisner","year":"1983","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0085","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/00007890-198906000-00013","article-title":"T cell depletion of human bone marrow. Comparison of campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads","volume":"47","author":"Frame","year":"1989","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0090","first-page":"21","article-title":"T cell depletion from human bone marrow using magnetic beads","volume":"6","author":"Knobloch","year":"1990","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/106161299320488","article-title":"Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device","volume":"8","author":"Schumm","year":"1999","journal-title":"J Hematother"},{"issue":"15","key":"10.1016\/j.blre.2016.03.001_bb0100","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.blre.2016.03.001_bb0105","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.bbmt.2011.02.002","volume":"17","author":"Devine","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0110","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.seminoncol.2012.09.007","article-title":"New approaches to graft engineering for haploidentical bone marrow transplantation","volume":"39","author":"Handgretinger","year":"2012","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood.V97.2.383","article-title":"The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings","volume":"97","author":"Urbano-Ispizua","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0120","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.178.2.703","article-title":"Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans","volume":"178","author":"Martin","year":"1993","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.blre.2016.03.001_bb0125","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Li","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.03.001_bb0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.med.54.101601.152456","article-title":"The current status of hematopoietic cell transplantation","volume":"54","author":"Appelbaum","year":"2003","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood.V98.5.1358","article-title":"Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection","volume":"98","author":"Gratama","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2016.03.001_bb0140","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V98.4.972","article-title":"Epstein\u2013Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT","volume":"98","author":"van Esser","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2016.03.001_bb0145","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.V82.7.2235.2235","article-title":"Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase","volume":"82","author":"Goldman","year":"1993","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0155","first-page":"616","article-title":"Principles of graft-vs-leukemia reactivity","volume":"1","author":"Truitt","year":"1995","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.blre.2016.03.001_bb0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/stem.150248","article-title":"Mechanisms of the graft-versus-leukemia reaction","volume":"15","author":"Barrett","year":"1997","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.blre.2016.03.001_bb0165","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1182\/blood-2006-05-023416","article-title":"Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation","volume":"109","author":"Ciceri","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(09)70074-9","article-title":"Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I\u2013II study","volume":"10","author":"Ciceri","year":"2009","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.blre.2016.03.001_bb0175","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.blre.2016.03.001_bb0180","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1182\/blood-2014-01-551671","article-title":"Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.blre.2016.03.001_bb0185","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood-2015-02-628354","article-title":"Inducible caspase-9 suicide gene controls adverse effects from allodeplete T cells after haploidentical stem cell transplantation","volume":"125","author":"Zhou","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.blre.2016.03.001_bb0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0200","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.coi.2008.07.004","article-title":"Role of KIRs and KIR ligands in hematopoietic transplantation","volume":"20","author":"Velardi","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.smim.2014.02.004","article-title":"Natural killer cells in the treatment of high-risk acute leukaemia","volume":"26","author":"Locatelli","year":"2014","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0210","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0215","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0220","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0225","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbmt.2014.01.032","article-title":"Engineering human peripheral blood stem cell grafts that are depleted of naive T cells and retain functional pathogen-specific memory T cells","volume":"20","author":"Bleakley","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2013.114","article-title":"Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis","volume":"49","author":"Teschner","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.blre.2016.03.001_bb0235","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.blre.2016.03.001_bb0240","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bmt.2015.135","article-title":"Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads","volume":"50","author":"Verfuerth","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.blre.2016.03.001_bb0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients","volume":"76","author":"Kolb","year":"1990","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2016.03.001_bb0250","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood.V98.4.934","article-title":"T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect","volume":"98","author":"Alyea","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2016.03.001_bb0255","first-page":"780","article-title":"Donor lymphocyte infusion for post-transplant relapse of Hodgkin's lymphoma","volume":"85","author":"De Rosa","year":"2000","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbmt.2007.04.013","article-title":"High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma","volume":"14","author":"Bloor","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0265","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.leu.2403721","article-title":"Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with myelomonocytic leukemia","volume":"19","author":"Yoshimi","year":"2005","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0270","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.leu.2404641","article-title":"Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy","volume":"21","author":"Simula","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0275","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.V76.2.418.418","article-title":"Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation","volume":"76","author":"Champlin","year":"1990","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0280","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2006-03-005769","article-title":"Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation","volume":"109","author":"Meyer","year":"2007","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.blre.2016.03.001_bb0285","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2008-10-183723","article-title":"Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: post-transplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery","volume":"113","author":"Dodero","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0290","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-02-001909","article-title":"Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation","volume":"108","author":"Amrolia","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2016.03.001_bb0295","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/S0041-1345(02)03491-7","article-title":"Donor T lymphocyte infusion following ex vivo depletion of donor anti-host reactivity by a specific anti-interleukin-2 receptor P55 chain immunotoxin","volume":"34","author":"Andr\u00e9-Schmutz","year":"2002","journal-title":"Transplant Proc"},{"issue":"9","key":"10.1016\/j.blre.2016.03.001_bb0300","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/bmt.2011.237","article-title":"Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT","volume":"47","author":"Perruccio","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0305","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.tp.0000256158.84418.ff","article-title":"Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity","volume":"83","author":"Durakovic","year":"2007","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0310","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V68.3.770.770","article-title":"Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease","volume":"68","author":"Kernan","year":"1986","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0315","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.158.2.571","article-title":"Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations","volume":"158","author":"Moretta","year":"1983","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0320","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3083.1985.tb01888.x","article-title":"Human cytotoxic T lymphocytes. I. Limiting-dilution analysis of alloreactive cytotoxic T-lymphocyte precursor frequencies","volume":"22","author":"Kabelitz","year":"1985","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0325","first-page":"149","article-title":"Frequency analysis of cytotoxic T lymphocyte precursors\u2014possible relevance to HLA-matched unrelated donor bone marrow transplantation","volume":"3","author":"Kaminski","year":"1988","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.blre.2016.03.001_bb0330","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1700779","article-title":"Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation","volume":"19","author":"Keever-Taylor","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0335","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood-2003-04-1098","article-title":"Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation","volume":"103","author":"Godfrey","year":"2004","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.blre.2016.03.001_bb0340","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.03.001_bb0345","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/bmt.2015.92","article-title":"HLA-haploidentical blood or marrow transplantation with high dose post transplant cyclophosphamide","volume":"50","author":"Fuchs","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0350","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1073\/pnas.0337543100","article-title":"Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences","volume":"100","author":"Mich\u00e0lek","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0355","first-page":"132","article-title":"Human naive CD4 T cell clones specific for HIV env persist for years in vivo in the absence of antigenic challenge","volume":"40","author":"Li Pira","year":"2005","journal-title":"J AIDS"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0360","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.161.2.594","article-title":"The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time","volume":"161","author":"Levitsky","year":"1998","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0365","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.exphem.2006.03.001","article-title":"Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering","volume":"34","author":"Scheinberg","year":"2006","journal-title":"Exp Hematol"},{"issue":"9","key":"10.1016\/j.blre.2016.03.001_bb0370","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.it.2005.07.005","article-title":"Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer","volume":"26","author":"Kern","year":"2005","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0375","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1073\/pnas.74.5.2104","article-title":"Nature of antigenic complexes recognized by T lymphocytes: specific sensitization by antigen associated with allogeneic macrophages","volume":"74","author":"Thomas","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0380","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1084\/jem.154.3.978","article-title":"Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from non-responder strains","volume":"154","author":"Ishi","year":"1981","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.blre.2016.03.001_bb0385","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1182\/blood-2007-08-104471","article-title":"A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique","volume":"111","author":"Mielke","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0390","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1532\/LH96.09010","article-title":"Identification and selective depletion of alloreactive T-cells for adoptive immunotherapy","volume":"16","author":"Rettinger","year":"2010","journal-title":"Lab Hematol"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0395","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.tp.0000167818.78950.f2","article-title":"A rapid test to monitor alloreactive responses in whole blood using real-time polymerase chain reaction","volume":"80","author":"Zhou","year":"2005","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0400","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood-2006-04-014100","article-title":"Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines","volume":"109","author":"Wehler","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0405","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/14653240510018181","article-title":"Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation","volume":"7","author":"Amrolia","year":"2005","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0410","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-11-3516","article-title":"Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses","volume":"102","author":"Amrolia","year":"2003","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.blre.2016.03.001_bb0415","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0198-8859(97)00107-9","article-title":"Peripheral blood mononuclear cell sonicates as an alternative to irradiated allogeneic cells to stimulate a mixed lymphocyte reaction and to enumerate CD69+ alloreactive T cells","volume":"56","author":"Leiva","year":"1997","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.blre.2016.03.001_bb0420","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/tan.12090","article-title":"Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies","volume":"81","author":"Warren","year":"2013","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0425","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2141.1999.01675.x","article-title":"Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease","volume":"107","author":"van Dijk","year":"1999","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.blre.2016.03.001_bb0430","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e31818810d6","article-title":"Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering","volume":"86","author":"Nonn","year":"2008","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.blre.2016.03.001_bb0435","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1182\/blood.V99.9.3083","article-title":"Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging","volume":"99","author":"Chen","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0440","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2001-12-0353","article-title":"P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells","volume":"100","author":"Guimond","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0445","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/j.seminoncol.2012.09.004","article-title":"Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation","volume":"39","author":"Bastien","year":"2012","journal-title":"Semin Oncol"},{"issue":"12","key":"10.1016\/j.blre.2016.03.001_bb0450","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.bbmt.2011.05.017","article-title":"Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome","volume":"17","author":"McIver","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.blre.2016.03.001_bb0455","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.bbmt.2011.05.019","article-title":"Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies","volume":"17","author":"Mielke","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0460","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.2910490324","article-title":"Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice","volume":"49","author":"Engert","year":"1991","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0465","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V89.2.403","article-title":"A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma","volume":"89","author":"Engert","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0470","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.leu.2401626","article-title":"Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin","volume":"14","author":"Schnell","year":"2000","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.blre.2016.03.001_bb0475","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1182\/blood.V93.10.3550.410k24_3550_3557","article-title":"Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity","volume":"93","author":"Montagna","year":"1999","journal-title":"Blood"},{"issue":"9327","key":"10.1016\/j.blre.2016.03.001_bb0480","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0140-6736(02)09413-8","article-title":"Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1\/2 study","volume":"360","author":"Andr\u00e9-Schmutz","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0485","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2005-01-0393","article-title":"Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation","volume":"106","author":"Solomon","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0490","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00007890-199901150-00021","article-title":"Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations","volume":"67","author":"Garderet","year":"1999","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0495","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/blood-2009-08-235895","article-title":"Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy","volume":"115","author":"Samarasinghe","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0500","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcyt.2012.10.007","article-title":"Optimization of methodology for production of CD25\/CD71 allodepleted donor T cells for clinical use","volume":"15","author":"Albon","year":"2013","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0505","first-page":"793","article-title":"Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation","volume":"17","author":"Mavroudis","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.blre.2016.03.001_bb0510","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.bmt.1701749","article-title":"Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis","volume":"23","author":"Koh","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0515","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.bmt.1705238","article-title":"Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes","volume":"37","author":"Hartwig","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0520","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3727\/096368914X679327","article-title":"Depletion of alloreactive T-cells by anti-CD137-saporin immunotoxin","volume":"24","author":"Lee","year":"2015","journal-title":"Cell Transplant"},{"issue":"12","key":"10.1016\/j.blre.2016.03.001_bb0525","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1182\/blood-2004-05-1918","article-title":"Functional assessment and specific depletion of alloreactive human T cells using flow cytometry","volume":"104","author":"Martins","year":"2004","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.blre.2016.03.001_bb0530","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.380.380","article-title":"Selective depletion of alloreactive donor T cells with adenosine: an efficient, scaleable, GMP-compliant, low-cost method to prevent GVHD while preserving antiviral and antileukemic activity in haploidentical stem cell transplant","volume":"126","author":"Whitehill","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0535","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0952-7915(93)90132-C","article-title":"T cell co-stimulation and in vivo tolerance","volume":"5","author":"Lenschow","year":"1993","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0540","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-065X.2011.01011.x","article-title":"Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28\/B7 family","volume":"241","author":"Bour-Jordan","year":"2011","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0545","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1182\/blood-2008-03-143636","article-title":"Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies","volume":"112","author":"Davies","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2016.03.001_bb0550","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/blood.V87.11.4887.bloodjournal87114887","article-title":"Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool","volume":"87","author":"Gribben","year":"1996","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.blre.2016.03.001_bb0555","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2009-06-224600","article-title":"Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease","volume":"114","author":"Stuehler","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.blre.2016.03.001_bb0560","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2005-05-2118","article-title":"Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines","volume":"107","author":"Blanco","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2016.03.001_bb0565","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.leukres.2011.05.018","article-title":"Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens","volume":"35","author":"Blanco","year":"2011","journal-title":"Leuk Res"},{"issue":"10","key":"10.1016\/j.blre.2016.03.001_bb0570","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bbmt.2013.08.004","article-title":"Selective allodepletion: have we finally found the holy graal?","volume":"19","author":"Fuchs","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0575","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00007890-198508000-00016","article-title":"Drug-induced tolerance to allografts in mice. tolerance induction in H2 haplotype identical strain combinations","volume":"40","author":"Mayumi","year":"1985","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0580","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.4049\/jimmunol.145.5.1303","article-title":"Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion","volume":"145","author":"Eto","year":"1990","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0585","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0590","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2016.03.001_bb0595","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.bbmt.2012.07.003","article-title":"Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation","volume":"18","author":"Ciurea","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0600","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","article-title":"Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning","volume":"19","author":"Raiola","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0605","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbmt.2014.03.003","article-title":"Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning","volume":"20","author":"Raj","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.blre.2016.03.001_bb0610","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1200\/JCO.2012.45.0247","article-title":"Graft-versus-host disease and graft versus tumor effects after allogeneic hematopoietic cell transplantation","volume":"31","author":"Storb","year":"2013","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.blre.2016.03.001_bb0615","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","article-title":"High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease","volume":"115","author":"Luznik","year":"2010","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.blre.2016.03.001_bb0620","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with post-transplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bolanos-Meade","year":"2012","journal-title":"Blood"},{"issue":"124","key":"10.1016\/j.blre.2016.03.001_bb0625","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003509","article-title":"Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hemopoietic stem cell transplantation","volume":"4","author":"Leventhal","year":"2012","journal-title":"Sci Transl Med"},{"issue":"211","key":"10.1016\/j.blre.2016.03.001_bb0630","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to post-transplantation cyclophosphamide","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.blre.2016.03.001_bb0635","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.bbmt.2015.04.025","article-title":"Post-transplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and peripheral blood stem cells","volume":"21","author":"Cieri","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0640","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bmt.1701537","article-title":"Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study","volume":"23","author":"Wiesmann","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.blre.2016.03.001_bb0645","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncponc0511","article-title":"Technology insight: ECP for the treatment of GvHD\u2014can we offer selective immune control without generalized immunosuppression","volume":"3","author":"Marshall","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"issue":"4","key":"10.1016\/j.blre.2016.03.001_bb0650","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-11-125542","article-title":"Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells","volume":"112","author":"Gatza","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0655","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.transci.2014.04.003","article-title":"Updating ECP action mechanisms","volume":"50","author":"Heshmati","year":"2014","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0660","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.coi.2009.08.006","article-title":"Pathogen specific T-lymphocytes for reconstitution of the immunocompromised host","volume":"21","author":"Li Pira","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"10.1016\/j.blre.2016.03.001_bb0665","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1073\/pnas.75.10.5145","article-title":"Biological significance of alloreactivity: T cell stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells","volume":"75","author":"Finberg","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.blre.2016.03.001_bb0670","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.179.4.1155","article-title":"An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein\u2013Barr virus CTL epitope: implications for graft-versus-host disease","volume":"179","author":"Burrows","year":"1994","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0675","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/viro.1999.9996","article-title":"Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein\u2013Barr virus in healthy virus carriers","volume":"264","author":"Benninger-D\u00f6ring","year":"1999","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.blre.2016.03.001_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012120","article-title":"Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules","volume":"5","author":"Morice","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.blre.2016.03.001_bb0685","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1473-3099(02)00370-5","article-title":"Infections and solid organ transplant rejection: a cause-and-effect relationship","volume":"2","author":"Cainelli","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.blre.2016.03.001_bb0690","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"issue":"5132","key":"10.1016\/j.blre.2016.03.001_bb0695","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1126\/science.8211163","article-title":"Expression of two T cell receptor alpha chains: dual receptor T cells","volume":"262","author":"Padovan","year":"1993","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.blre.2016.03.001_bb0700","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.4049\/jimmunol.0900638","article-title":"Cutting edge: highly alloreactive dual TCR T cells play a dominant role in graft-versus-host disease","volume":"182","author":"Morris","year":"2009","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.blre.2016.03.001_bb0705","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jim.2012.01.001","article-title":"Selective binding of CD4 and CD8 T-cells to antigen presenting cells for enrichment of CMV and HIV specific T-lymphocytes","volume":"376","author":"Li Pira","year":"2012","journal-title":"J Immunol Methods"},{"issue":"7","key":"10.1016\/j.blre.2016.03.001_bb0710","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1182\/blood-2007-09-113522","article-title":"Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells","volume":"111","author":"Sch\u00fctz","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2016.03.001_bb0715","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/imt.10.26","article-title":"Killer artificial antigen-presenting cells: the synthetic embodiment of a \u2018guided missile\u2019","volume":"2","author":"Sch\u00fctz","year":"2010","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0720","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.imlet.2011.04.002","article-title":"Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation","volume":"138","author":"Shen","year":"2011","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0725","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2567.2009.03080.x","article-title":"T-cell reconstitution without T-cell immunopathology in two models of T-cell-mediated tissue destruction","volume":"128","author":"Penaloza-MacMaster","year":"2009","journal-title":"Immunology"},{"issue":"1\u20132","key":"10.1016\/j.blre.2016.03.001_bb0730","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jim.2012.07.022","article-title":"Lymphocyte proliferation specific for recall, CMV and HIV antigens in miniaturized and automated format","volume":"384","author":"Li Pira","year":"2012","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0735","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cei.12052","article-title":"Promoting transplantation tolerance; adoptive regulatory T cell therapy","volume":"172","author":"Safinia","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"83","key":"10.1016\/j.blre.2016.03.001_bb0740","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.blre.2016.03.001_bb0745","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2249.2009.03901.x","article-title":"Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications","volume":"156","author":"Di Ianni","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"23","key":"10.1016\/j.blre.2016.03.001_bb0750","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1182\/blood-2010-03-273193","article-title":"Photodepletion differentially affects CD4+ tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease","volume":"116","author":"Bastien","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2016.03.001_bb0755","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/1744666X.2016.1123091","article-title":"Strategies to accelerate imune recovery after allogenic hematopoietic stem cell transplantation","volume":"12","author":"Lucarelli","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"1\u20132","key":"10.1016\/j.blre.2016.03.001_bb0760","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jim.2010.02.010","article-title":"Validation of a miniaturized method for assessment of specific T cell immunity","volume":"355","author":"Li Pira","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.blre.2016.03.001_bb0765","series-title":"The T cell receptor","author":"Lefranc","year":"2001"},{"key":"10.1016\/j.blre.2016.03.001_bb0770","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.iy.04.040186.002525","article-title":"The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition","volume":"4","author":"Kronenberg","year":"1986","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.blre.2016.03.001_bb0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(77)90269-6","article-title":"Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?","volume":"29","author":"Matzinger","year":"1977","journal-title":"Cell Immunol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T06:58:27Z","timestamp":1692255507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X16000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":155,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0268960X16000126"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2016.03.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific removal of alloreactive T-cells to prevent GvHD in hemopoietic stem cell transplantation: rationale, strategies and perspectives","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}